Calendar Cerus Corporation

Equities

CERS

US1570851014

Real-time Estimate Cboe BZX 01:15:32 2024-06-11 pm EDT 5-day change 1st Jan Change
1.755 USD +0.29% Intraday chart for Cerus Corporation -3.06% -19.21%

Chart calendar Cerus Corporation

880661557c4e234edb6fe92d23eee.XAm8KgG5n4sIgMxUYNDcKsmL4qL0QgYwgJf7RAi6BeE.anjqb27N5sFqyrgRDbGSTYPK0P2GGG8GxciMAkTLUYotRe8ZS_qn0kf6_A~bd6399dd7147b099b0f0243ef7a1cea6

Upcoming events on Cerus Corporation

2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Cerus Corporation

2024-06-05 11:00 am Annual General Meeting
2024-05-28 Craig Hallum Institutional Investor Conference
2024-05-02 04:30 pm Q1 2024 Earnings Call
2024-05-02 04:00 pm Q1 2024 Earnings Release
2024-03-19 09:00 am INTERCEPT Blood System for Red Blood Cells in Cardiovascular Phase III Clinical Trial Results Call
2024-03-06 11:10 am TD Cowen Health Care Conference
2024-03-05 04:30 pm Q4 2023 Earnings Call
2024-03-05 04:00 pm Q4 2023 Earnings Release
2024-02-12 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
2023-11-15 01:00 pm Stephens Investment Conference - Fireside Chat
2023-11-14 04:10 pm Stifel Healthcare Conference - Fireside Chat
2023-11-02 04:30 pm Q3 2023 Earnings Call
2023-11-02 04:00 pm Q3 2023 Earnings Release
2023-10-16 05:30 pm Association for the Advancement of Blood & Biotherapies Meeting - Implementation Of 100% Pathogen-Re
2023-10-16 07:00 am Association for the Advancement of Blood & Biotherapies Meeting - Expanding the Use of Pathogen Redu
2023-10-15 10:00 am Association for the Advancement of Blood & Biotherapies Meeting - Pathogen Reduced Cryoprecipitate
2023-09-26 10:30 am Cantor Global Healthcare Conference
2023-08-02 04:30 pm Q2 2023 Earnings Call
2023-08-02 04:00 pm Q2 2023 Earnings Release
2023-06-21 03:15 am Regional International Society of Blood Transfusion Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
74,6
74,1
0.72%
91,9
90,7
1.34%
131
131
-0.03%
162
170
-4.48%
156
175
-10.44%

174

EBITDA
Million USD
Released
Forecast
Spread
-63,8
0,00
-
-55,2
0,00
-
-45,8
-28,5
-60.61%
-12,4
-9,15
-36.05%
-10,7
-13,1
18.16%

3,12

EBIT
Million USD
Released
Forecast
Spread
-66,2
-66,6
0.5%
-58,3
-58,1
-0.47%
-48,9
-54,6
10.39%
-34,1
-32,3
-5.47%
-30,1
-32,1
6.37%

-17,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-71,0
-70,9
-0.13%
-59,6
-59,9
0.59%
-54,1
-58,6
7.78%
-42,3
-38,2
-10.93%
-37,3
-39,5
5.4%

-25,4

Net income
Million USD
Released
Forecast
Spread
-71,2
-71,1
-0.23%
-59,9
-60,1
0.43%
-54,4
-58,9
7.62%
-42,8
-38,3
-11.58%
-37,5
-39,8
5.75%

-25,6

EPS
USD
Released
Forecast
Spread
-0,51
-0,51
-0.66%
-0,37
-0,37
-0.68%
-0,32
-0,35
7.25%
-0,24
-0,22
-10.34%
-0,21
-0,22
5.62%

-0,14

Announcement Date20/02/2025/02/2122/02/2228/02/2305/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
37,4
37,5
-0.12%
41,0
42,8
-4.11%
39,6
40,2
-1.53%
44,0
43,5
1.3%
31,0
37,0
-16.3%
38,9
41,8
-7%
39,8
42,8
-7%
46,8
52,0
-10.03%
38,4
38,3
0.04%

42,5


44,0


48,9


41,7


46,4

EBITDA
Million USD
Released
Forecast
Spread
-3,66
-7,38
50.41%
-2,41
-4,04
40.2%
-2,68
-2,50
-7.06%
-3,70
-1,03
-258.26%
-9,75
-4,97
-96.39%
-4,74
-5,17
8.29%
-0,97
-3,51
72.34%
4,74
2,39
98.47%
-2,71
-1,92
-41.31%

-0,41


1,23


5,00


-0,68


2,64

EBIT
Million USD
Released
Forecast
Spread
-9,85
-14,2
30.87%
-6,84
-11,0
38.01%
-7,45
-9,29
19.85%
-9,95
-8,20
-21.29%
-14,1
-13,2
-7.4%
-9,51
-9,27
-2.57%
-5,24
-8,33
37.09%
0,98
-2,13
145.76%
-7,98
-7,26
-9.93%

-5,67


-3,81


-0,44


-6,19


-2,73

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-12,2
-14,4
15.44%
-8,32
-12,4
32.68%
-8,45
-10,6
20.17%
-13,4
-9,24
-44.57%
-15,6
-15,9
1.94%
-13,2
-10,9
-21.72%
-7,21
-9,74
26.01%
-1,32
-4,66
71.72%
-9,62
-8,88
-8.27%

-7,65


-6,08


-2,38


-7,77


-4,30

Net income
Million USD
Released
Forecast
Spread
-12,3
-14,5
15.46%
-8,39
-12,4
32.34%
-8,48
-10,6
20.05%
-13,6
-9,24
-47.45%
-15,6
-14,7
-6.51%
-13,3
-10,4
-27.15%
-7,27
-9,83
26.11%
-1,33
-4,73
71.91%
-9,69
-8,92
-8.65%

-7,71


-6,09


-2,42


-7,80


-4,33

EPS
USD
Released
Forecast
Spread
-0,07
-0,08
15.15%
-0,06
-0,07
14.29%
-0,05
-0,06
13.04%
-0,08
-0,06
-45.45%
-0,09
-0,08
-8%
-0,07
-0,06
-21.74%
-0,04
-0,05
25%
-0,01
-0,03
63.64%
-0,05
-0,05
-4.17%

-0,04


-0,03


-0,01


-0,04


-0,02

Announcement Date05/05/2204/08/2203/11/2228/02/2304/05/2302/08/2302/11/2305/03/2402/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CERS Stock
  4. Calendar Cerus Corporation